Expression profiling of skeletal muscle following acute and chronic β2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm
暂无分享,去创建一个
[1] C. Mammucari,et al. Smad2 and 3 transcription factors control muscle mass in adulthood. , 2009, American journal of physiology. Cell physiology.
[2] T. McDaneld,et al. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt. , 2008, Journal of animal science.
[3] J. Zierath,et al. Relationship between AMPK and the transcriptional balance of clock-related genes in skeletal muscle. , 2008, American journal of physiology. Endocrinology and metabolism.
[4] C. Brenner,et al. Faculty Opinions recommendation of AMPK and PPARdelta agonists are exercise mimetics. , 2008 .
[5] Maria M. Mihaylova,et al. AMPK and PPARδ Agonists Are Exercise Mimetics , 2008, Cell.
[6] K. Wagner,et al. Myostatin Directly Regulates Skeletal Muscle Fibrosis* , 2008, Journal of Biological Chemistry.
[7] G. Muscat,et al. The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. , 2008, Endocrinology.
[8] G. Lynch,et al. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. , 2008, Physiological reviews.
[9] Jeong-Ho Kim,et al. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components. , 2008, Endocrinology.
[10] E. Henriksen,et al. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3. , 2008, American journal of physiology. Endocrinology and metabolism.
[11] R. DePinho,et al. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. , 2007, The Journal of clinical investigation.
[12] Zidong Zhang,et al. Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. , 2007, Molecular endocrinology.
[13] Erin L. McDearmon,et al. Identification of the circadian transcriptome in adult mouse skeletal muscle. , 2007, Physiological genomics.
[14] S. Miura,et al. An Increase in Murine Skeletal Muscle Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α (PGC-1α) mRNA in Response to Exercise Is Mediated by β-Adrenergic Receptor Activation , 2007 .
[15] Sushma Sharma,et al. Ultrastructural findings for the mitochondrial subpopulation of mice skeletal muscle after adrenergic stimulation by clenbuterol. , 2007, The journal of physiological sciences : JPS.
[16] D. Allen,et al. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. , 2006, American journal of physiology. Cell physiology.
[17] E. Shimizu,et al. Circadian rhythms in the CNS and peripheral clock disorders: function of clock genes: influence of medication for bronchial asthma on circadian gene. , 2007, Journal of pharmacological sciences.
[18] S. Miura,et al. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation. , 2007, Endocrinology.
[19] L. McIntyre,et al. Changes in skeletal muscle gene expression following clenbuterol administration , 2006, BMC Genomics.
[20] G. Muscat,et al. The orphan nuclear receptor, NOR-1, is a target of beta-adrenergic signaling in skeletal muscle. , 2006, Endocrinology.
[21] Nicholas Ling,et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF‐κB‐independent, FoxO1‐dependent mechanism , 2006 .
[22] Weimin He,et al. Nuclear Receptor Expression Links the Circadian Clock to Metabolism , 2006, Cell.
[23] T. McDaneld,et al. Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[24] M. Sillence,et al. Systemic administration of β2‐adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses , 2006, British journal of pharmacology.
[25] I. Kettelhut,et al. CL 316,243, a selective β3-adrenergic agonist, inhibits protein breakdown in rat skeletal muscle , 2006, Pflügers Archiv.
[26] M. Tamura,et al. Cross-talk between Wnt and Bone Morphogenetic Protein 2 (BMP-2) Signaling in Differentiation Pathway of C2C12 Myoblasts* , 2005, Journal of Biological Chemistry.
[27] S. McGee,et al. Effect of carbohydrate ingestion on exercise-induced alterations in metabolic gene expression. , 2005, Journal of applied physiology.
[28] M. Tarnopolsky,et al. The FASEB Journal express article 10.1096/fj.04-3149fje. Published online June 28, 2005. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise , 2022 .
[29] F. McArdle,et al. Intracellular generation of reactive oxygen species by contracting skeletal muscle cells. , 2005, Free radical biology & medicine.
[30] G. Perseghin. Muscle lipid metabolism in the metabolic syndrome , 2005, Current opinion in lipidology.
[31] S. Dodd,et al. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. , 2005, Journal of applied physiology.
[32] Y. Donati,et al. Hyperoxia‐mediated oxidative stress increases expression of UCP3 mRNA and protein in skeletal muscle , 2005, FEBS letters.
[33] G. Cooney,et al. Nur77 Regulates Lipolysis in Skeletal Muscle Cells , 2005, Journal of Biological Chemistry.
[34] E. Shimizu,et al. β2‐Adrenoceptor Agonists Induce the Mammalian Clock Gene, hPer1, mRNA in Cultured Human Bronchial Epithelium Cells in vitro , 2005, Chronobiology international.
[35] W. Saris,et al. Impaired β-adrenergically mediated lipolysis in skeletal muscle of obese subjects , 2004, Diabetologia.
[36] D. E. Moody,et al. Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of beta-adrenergic receptor agonists. , 2004, Physiological genomics.
[37] P. Pévet,et al. Daily rhythm and regulation of clock gene expression in the rat pineal gland. , 2004, Brain research. Molecular brain research.
[38] R. Feneberg,et al. Circadian Rhythm of Glucose Uptake in Cultures of Skeletal Muscle Cells and Adipocytes in Wistar-Kyoto, Wistar, Goto-Kakizaki, and Spontaneously Hypertensive Rats , 2004, Chronobiology international.
[39] G. Muscat,et al. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. , 2003, Molecular endocrinology.
[40] Nathan Salomonis,et al. Time- and exercise-dependent gene regulation in human skeletal muscle , 2003, Genome Biology.
[41] W. Saris,et al. Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. , 2003, American journal of physiology. Endocrinology and metabolism.
[42] T. McDaneld,et al. Characterization of a bovine gene encoding an ankyrin repeat and SOCS box protein (ASB15). , 2003, Animal Genetics.
[43] S. Shibata,et al. Adrenergic regulation of clock gene expression in mouse liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Roy,et al. Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres. , 2002, Acta physiologica Scandinavica.
[45] J. Nevzorova,et al. Characterization of the β‐adrenoceptor subtype involved in mediation of glucose transport in L6 cells , 2002, British journal of pharmacology.
[46] B. Lowell,et al. βAR Signaling Required for Diet-Induced Thermogenesis and Obesity Resistance , 2002, Science.
[47] V. Nevzorova,et al. [Cytological and biochemical indices of induced sputum in patients with bronchial asthma and chronic obstructive bronchitis]. , 2002, Tsitologiya.
[48] C. Maltin,et al. Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism. , 2001, American journal of physiology. Endocrinology and metabolism.
[49] R. H. Migliorini,et al. Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP. , 2001, American journal of physiology. Endocrinology and metabolism.
[50] A. Medvedev,et al. β-Adrenergic Activation of p38 MAP Kinase in Adipocytes , 2001, The Journal of Biological Chemistry.
[51] M. Saito,et al. Up‐regulation of uncoupling proteins by β‐adrenergic stimulation in L6 myotubes , 2001 .
[52] F. Murad,et al. Down-regulation of inducible nitric-oxide synthase (NOS-2) during parasite-induced gut inflammation: a path to identify a selective NOS-2 inhibitor. , 2001, Molecular pharmacology.
[53] A. Medvedev,et al. beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. , 2001, The Journal of biological chemistry.
[54] M. Saito,et al. Up-regulation of uncoupling proteins by beta-adrenergic stimulation in L6 myotubes. , 2001, FEBS letters.
[55] H. Okamura,et al. Differential adrenergic regulation of the circadian expression of the clock genes Period1 and Period2 in the rat pineal gland , 2000, The European journal of neuroscience.
[56] B. Miroux,et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production , 2000, Nature Genetics.
[57] I. Kettelhut,et al. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. , 2000, American journal of physiology. Endocrinology and metabolism.
[58] B. Lowell,et al. Role of the β3-Adrenergic Receptor and/or a Putative β4-Adrenergic Receptor on the Expression of Uncoupling Proteins and Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 , 1999 .
[59] B. Lowell,et al. Role of the beta(3)-adrenergic receptor and/or a putative beta(4)-adrenergic receptor on the expression of uncoupling proteins and peroxisome proliferator-activated receptor-gamma coactivator-1. , 1999, Biochemical and biophysical research communications.
[60] P. Arner,et al. β-Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo. , 1998, American journal of physiology. Endocrinology and metabolism.
[61] Naoya Yamamoto,et al. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. , 1997, Biochemical and biophysical research communications.
[62] C. Maltin,et al. Clenbuterol increases the expression of myogenin but not myoD in immobilized rat muscles. , 1997, The American journal of physiology.
[63] S. Powers,et al. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle. , 1996, Medicine and science in sports and exercise.
[64] S. Kooi,et al. Norepinephrine Release in the Rat Pineal Gland: The Input from the Biological Clock Measured by In Vivo Microdialysis , 1996, Journal of neurochemistry.
[65] H. Hartung,et al. H2O2 and Nitric Oxide‐mediated Oxidative Stress Induce Apoptosis in Rat Skeletal Muscle Myoblasts , 1996, Journal of neuropathology and experimental neurology.
[66] R. Morton,et al. Effect of the beta 2-adrenergic agonist clenbuterol on the growth of fast- and slow-twitch skeletal muscle of the dystrophic (C57BL6J dy2J/dy2J) mouse. , 1995, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.
[67] L. Tessitore,et al. Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. , 1995, The Journal of clinical investigation.
[68] W. Saris,et al. Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. , 1994, The American journal of physiology.
[69] W. Bergen,et al. Skeletal muscle growth and expression of skeletal muscle alpha-actin mRNA and insulin-like growth factor I mRNA in pigs during feeding and withdrawal of ractopamine. , 1993, Journal of animal science.
[70] J. Bülow,et al. Thermogenic response to epinephrine in the forearm and abdominal subcutaneous adipose tissue. , 1992, The American journal of physiology.
[71] P. Buttery,et al. Changes in calpain and calpastatin mRNA induced by beta-adrenergic stimulation of bovine skeletal muscle. , 1992, European journal of biochemistry.
[72] E. Agbenyega,et al. Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone. , 1992, Comparative biochemistry and physiology. Comparative physiology.
[73] A. K. Lockley,et al. Effect of beta-agonists on expression of calpain and calpastatin activity in skeletal muscle. , 1992, Biochimie.
[74] S. Shackelford,et al. Effect of the beta-adrenergic agonist L644,969 on muscle growth, endogenous proteinase activities, and postmortem proteolysis in wether lambs. , 1991, Journal of animal science.
[75] J. Fagan,et al. Effect of Beta Agonists on Protein Turnover in Isolated Chick Skeletal and Atrial Muscle , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[76] M. Laakso,et al. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy. , 1991, The Journal of clinical investigation.
[77] E. Agbenyega,et al. Effect of clenbuterol on normal and denervated muscle growth and contractility , 1990, Muscle & nerve.
[78] C. Maltin,et al. Evidence that the hypertrophic action of clenbuterol on denervated rat muscle is not propranolol‐sensitive , 1989, British journal of pharmacology.
[79] J. D. Etlinger,et al. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist. , 1988, The American journal of physiology.
[80] C. Maltin,et al. Clenbuterol, a beta agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms , 1987, Bioscience reports.
[81] J. D. Etlinger,et al. Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles. , 1987, The American journal of physiology.
[82] P. Reeds,et al. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis , 1986, British Journal of Nutrition.
[83] U. Moritz,et al. Thermogenesis in human skeletal muscle as measured by direct microcalorimetry and muscle contractile performance during beta-adrenoceptor blockade. , 1986, Clinical science.
[84] N. Christensen,et al. Sympathetic nervous activity during exercise. , 1983, Annual review of physiology.
[85] G. Brooks,et al. Free radicals and tissue damage produced by exercise. , 1982, Biochemical and biophysical research communications.
[86] J. Leblanc,et al. Protein synthesis, amino acid uptake, and pools during isoproterenol-induced hypertrophy of the rat heart and tibialis muscle. , 1981, Canadian journal of physiology and pharmacology.
[87] C. Dillard,et al. Effects of exercise, vitamin E, and ozone on pulmonary function and lipid peroxidation. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.
[88] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.